IGF1R and metabolic dysfunction-associated steatotic liver disease: MASLD and diabetes, as well as abnormal insulin and IGF-1 signaling, have been identified as important risk factors and contributors to HCC development.[39], [40], [41] This study provides evidence that IR and IGF1R are components in the process of hepatocarcinogenesis induced by hepatic PTEN deletion.